Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neovascularization, Pathologic × Surveys and Questionnaires × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 9 Prostatic Neoplasms 8 Head and Neck Neoplasms 8 Colorectal Neoplasms 8 Motor Activity 6 Breast Neoplasms 6 Ovarian Neoplasms 4 Multiple Myeloma 4 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Oropharyngeal Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Mouth Neoplasms 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Leiomyoma 2 Hematological Cancer 2 Hematologic Neoplasms 2 Colonic Neoplasms 2 COVID-19 2 Brain Neoplasms 2 Wilms Tumor 1 Venous Thromboembolism 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1

Interventions

Surveys and Questionnaires 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05741671 2023-02-23

MYOVASC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Leiomyoma, Neovascularization, Pathologic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡